Excess vascularity and fibrosis are key risk factors that lead to excess scarring and failure in glaucoma surgery. CBT-007 uses anti-angiogenic and anti-fibrotic mechanisms to increase the rate of success of glaucoma surgery.
© 2023 Cloudbreak Pharma All Rights Reserved.